Insider Trading & Ownership - X4 Pharmaceuticals Inc (XFOR)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for X4 Pharmaceuticals Inc
Goto 0, 1, 2, 3, 4, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-11-15
Sale
2024-11-19
4:31 pm
X4 Pharmaceuticals IncXFORRagan Paula
President and CEO
31,897$0.3945$12,583993,919
(Direct)
View
2024-10-15
Sale
2024-10-16
4:54 pm
X4 Pharmaceuticals IncXFORRagan Paula
President and CEO
31,897$0.562$17,9261,025,816
(Direct)
View
2024-10-07
Sale
2024-10-08
4:44 pm
X4 Pharmaceuticals IncXFORMostafa Adam S.
Chief Financial Officer
230,645$0.5502$126,9010
(Direct)
View
2024-10-07
Sale
2024-10-08
4:44 pm
X4 Pharmaceuticals IncXFORBaldry Mark
Chief Commercial Officer
11,127$0.5847$6,50648,509
(Direct)
View
2024-10-07
Sale
2024-10-08
4:44 pm
X4 Pharmaceuticals IncXFORRagan Paula
President and CEO
239,436$0.5493$131,5221,057,713
(Direct)
View
2024-10-07
Sale
2024-10-08
4:44 pm
X4 Pharmaceuticals IncXFORDiBiase Mary
Chief Operating Officer
67,695$0.5662$38,329452,060
(Direct)
View
2024-10-07
Sale
2024-10-08
4:44 pm
X4 Pharmaceuticals IncXFORTaveras Arthur
Chief Scientific Officer
76,920$0.563$43,306388,026
(Direct)
View
2024-09-09
Sale
2024-09-11
4:01 pm
X4 Pharmaceuticals IncXFORDiBiase Mary
Chief Operating Officer
2,642$0.6577$1,738289,110
(Direct)
View
2024-03-11
Sale
2024-03-11
5:20 pm
X4 Pharmaceuticals IncXFORTaveras Arthur
Chief Scientific Officer
14,235$0.8818$12,552234,301
(Direct)
View
2024-03-11
Sale
2024-03-11
5:20 pm
X4 Pharmaceuticals IncXFORRagan Paula
President and CEO
49,678$0.8828$43,856765,068
(Direct)
View
2024-03-11
Sale
2024-03-11
5:19 pm
X4 Pharmaceuticals IncXFORMostafa Adam S.
Chief Financial Officer
52,500$0.8828$46,3470
(Direct)
View
2024-03-11
Sale
2024-03-11
5:19 pm
X4 Pharmaceuticals IncXFORDiBiase Mary
Chief Operating Officer
15,409$0.882$13,591291,752
(Direct)
View
2024-02-12
Sale
2024-02-12
5:23 pm
X4 Pharmaceuticals IncXFORDiBiase Mary
Chief Operating Officer
3,683$1.007$3,709307,161
(Direct)
View
2024-02-12
Sale
2024-02-12
5:23 pm
X4 Pharmaceuticals IncXFORTaveras Arthur
Chief Scientific Officer
787$1.0072$793248,536
(Direct)
View
2024-02-12
Sale
2024-02-12
5:05 pm
X4 Pharmaceuticals IncXFORRagan Paula
President and CEO
21,695$1.0091$21,892814,746
(Direct)
View
2024-02-12
Sale
2024-02-12
5:03 pm
X4 Pharmaceuticals IncXFORMostafa Adam S.
Chief Financial Officer
27,721$1.0091$27,97352,500
(Direct)
View
2023-11-01
Sale
2023-11-03
5:26 pm
X4 Pharmaceuticals IncXFORRagan Paula
President and CEO
239,437$0.75833$181,573836,441
(Direct)
View
2023-11-01
Sale
2023-11-03
4:42 pm
X4 Pharmaceuticals IncXFORMostafa Adam S.
Chief Financial Officer
230,645$0.73$168,37180,221
(Direct)
View
2023-11-01
Sale
2023-11-03
4:40 pm
X4 Pharmaceuticals IncXFORDiBiase Mary
Chief Operating Officer
67,695$0.73$49,417310,844
(Direct)
View
2023-11-01
Sale
2023-11-03
4:39 pm
X4 Pharmaceuticals IncXFORBaldry Mark
Chief Commercial Officer
10,257$0.73$7,48824,690
(Direct)
View
2023-11-01
Sale
2023-11-03
4:39 pm
X4 Pharmaceuticals IncXFORTaveras Arthur
Chief Scientific Officer
67,695$0.73$49,417249,323
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-10-04
Option Award
2024-10-08
4:44 pm
N/A
N/A
X4 Pharmaceuticals IncXFORMostafa Adam S.
Chief Financial Officer
230,645$00
(Direct)
View
2024-10-04
Option Award
2024-10-08
4:44 pm
N/A
N/A
X4 Pharmaceuticals IncXFORBaldry Mark
Chief Commercial Officer
34,946$048,509
(Direct)
View
2024-10-04
Option Award
2024-10-08
4:44 pm
N/A
N/A
X4 Pharmaceuticals IncXFORRagan Paula
President and CEO
532,081$01,057,713
(Direct)
View
2024-10-04
Option Award
2024-10-08
4:44 pm
N/A
N/A
X4 Pharmaceuticals IncXFORDiBiase Mary
Chief Operating Officer
230,645$0452,060
(Direct)
View
2024-10-04
Option Award
2024-10-08
4:44 pm
N/A
N/A
X4 Pharmaceuticals IncXFORTaveras Arthur
Chief Scientific Officer
230,645$0388,026
(Direct)
View
2024-06-10
Option Award
2024-06-11
4:13 pm
N/A
N/A
X4 Pharmaceuticals IncXFORde Craecker Francoise
Director
45,000$096,667
(Direct)
View
2024-06-10
Option Award
2024-06-11
4:13 pm
N/A
N/A
X4 Pharmaceuticals IncXFORAliski William
Director
45,000$096,667
(Direct)
View
2024-06-10
Option Award
2024-06-11
4:13 pm
N/A
N/A
X4 Pharmaceuticals IncXFORMCGIRR DAVID W J
Director
45,000$096,667
(Direct)
View
2024-06-10
Option Award
2024-06-11
4:13 pm
N/A
N/A
X4 Pharmaceuticals IncXFORStewart Murray
Director
45,000$0191,504
(Direct)
View
2024-06-10
Option Award
2024-06-11
4:12 pm
N/A
N/A
X4 Pharmaceuticals IncXFORBridger Gary
Director
45,000$096,667
(Direct)
View
2024-06-10
Option Award
2024-06-11
4:12 pm
N/A
N/A
X4 Pharmaceuticals IncXFORWoods Keith
Director
45,000$0135,000
(Direct)
View
2024-06-10
Option Award
2024-06-11
4:12 pm
N/A
N/A
X4 Pharmaceuticals IncXFORLawton Alison Frances
Director
45,000$096,667
(Direct)
View
2024-06-10
Option Award
2024-06-11
4:12 pm
N/A
N/A
X4 Pharmaceuticals IncXFORWYZGA MICHAEL S
Director
45,000$0121,667
(Direct)
View
2024-02-13
Option Award(A)
2024-02-28
5:52 pm
N/A
2034-02-13
X4 Pharmaceuticals IncXFORArbet-Engels Christophe
Chief Medical Officer
180,816$0180,816
(Direct)
View
2024-02-13
Option Award
2024-02-16
5:11 pm
N/A
2034-02-13
X4 Pharmaceuticals IncXFORArbet-Engels Christophe
Chief Medical Officer
475,831$0475,831
(Direct)
View
2024-02-13
Option Award
2024-02-16
5:10 pm
N/A
2034-02-13
X4 Pharmaceuticals IncXFORMostafa Adam S.
Chief Financial Officer
523,414$0523,414
(Direct)
View
2024-02-13
Option Award
2024-02-16
5:09 pm
N/A
2034-02-13
X4 Pharmaceuticals IncXFORDiBiase Mary
Chief Operating Officer
428,248$0428,248
(Direct)
View
2024-02-13
Option Award
2024-02-16
5:09 pm
N/A
2034-02-13
X4 Pharmaceuticals IncXFORRagan Paula
President and CEO
1,189,578$01,189,578
(Direct)
View
2024-02-13
Option Award
2024-02-16
5:09 pm
N/A
2034-02-13
X4 Pharmaceuticals IncXFORBaldry Mark
Chief Commercial Officer
523,414$0523,414
(Direct)
View
2024-02-13
Option Award
2024-02-16
5:08 pm
N/A
2034-02-13
X4 Pharmaceuticals IncXFORTaveras Arthur
Chief Scientific Officer
428,248$0428,248
(Direct)
View
2023-10-31
Option Award
2023-11-02
5:04 pm
N/A
N/A
X4 Pharmaceuticals IncXFORMostafa Adam S.
Chief Financial Officer
230,645$0310,866
(Direct)
View
2023-10-31
Option Award
2023-11-02
5:00 pm
N/A
N/A
X4 Pharmaceuticals IncXFORBaldry Mark
Chief Commercial Officer
34,947$034,947
(Direct)
View
2023-10-31
Option Award
2023-11-02
4:59 pm
N/A
N/A
X4 Pharmaceuticals IncXFORTaveras Arthur
Chief Scientific Officer
230,645$0317,018
(Direct)
View
2023-10-31
Option Award
2023-11-02
4:58 pm
N/A
N/A
X4 Pharmaceuticals IncXFORRagan Paula
President and CEO
532,081$01,075,878
(Direct)
View
(A) Indicate amendment filing.
Goto 0, 1, 2, 3, 4, Next